Paterna Biosciences
PrivateLast Round
Series A
May 13, 2026
Total Funding Raised
$13.53M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Paterna Biosciences operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. Its latest recorded funding round was a Seed round in October 2024.
Paterna Biosciences is a biotechnology company that develops in-vitro spermatogenesis (IVS) technology to treat male infertility.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paterna Biosciences Comparables
Compare Paterna Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kallistem | 80% | |
| Ovelle Bio Corp. | 73% | |
| Conception | 73% |
For institutional investors. Book with your work email.
Paterna Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 13, 2026 | ||||
| Seed | Oct 28, 2024 | ||||
| Seed | Mar 14, 2024 | ||||
| Seed | Aug 31, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Paterna Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| e184 | Seed |
| Freya Ventures | Seed |
| Utah Innovation Fund | Seed |
| Seaside Ventures | Seed |
| Capita3 | Seed |
| SpringTide Ventures | Seed |
| Divergent Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 61% MoM, reaching 4.9K.
- Oct 28, 2024
$11.4M round led by SpringTide Ventures
For institutional investors. Book with your work email.
Paterna Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Paterna Biosciences's valuation, stock price, and market status.
Is Paterna Biosciences a public or private company?
Paterna Biosciences is a private company.
What is the current stock price of Paterna Biosciences?
Paterna Biosciences is a private company, so its shares have no public market price. Caplight tracks Paterna Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Paterna Biosciences worth (valuation)?
Valuation information for Paterna Biosciences is not publicly available.
Can I buy Paterna Biosciences stock?
Paterna Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Paterna Biosciences's last funding round?
Paterna Biosciences's most recent funding round was Series A on May 13, 2026.
Who are the main investors in Paterna Biosciences?
Key investors in Paterna Biosciences include SpringTide Ventures.
Will Paterna Biosciences IPO soon?
No public IPO plans have been announced for Paterna Biosciences.
How can I track Paterna Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Paterna Biosciences's shares on secondary markets.